Common Stock, Shares Authorized |
1B |
shares |
|
Q3 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
16M |
shares |
|
Q3 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
8.32M |
USD |
-29.8% |
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
112K |
USD |
|
Q3 2024 |
Q2 2025 |
Operating Lease, Liability |
730K |
USD |
|
Q3 2024 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid |
758K |
USD |
|
Q3 2024 |
Q2 2025 |
Operating Lease, Liability, Current |
534K |
USD |
|
Q3 2024 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
450K |
USD |
|
Q1 2024 |
FY 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
453K |
USD |
|
Q3 2024 |
Q2 2025 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.06 |
pure |
|
Q3 2024 |
Q2 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
28K |
USD |
|
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
112K |
USD |
|
Q3 2024 |
Q2 2025 |
Additional Paid in Capital |
14.9M |
USD |
+212% |
Q1 2024 |
FY 2024 |